Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Total
Balances at Dec. 31, 2018 $ 5,838 $ 1,244,273 $ (1,481,973) $ (231,862)
Balances (in Shares) at Dec. 31, 2018 5,838,149      
Surrender of common shares in settlement of due from stockholder balance $ (575) (1,608,258) (1,608,833)
Surrender of common shares in settlement of due from stockholder balance (in Shares) (574,991)      
Series A Convertible Preferred share issuance (Alliance MMA) $ 619 5,980,326 5,980,945
Series A Convertible Preferred share issuance (Alliance MMA) (in Shares) 619,138      
Conversion of Series A Convertible Preferred Stock into common stock $ (158) $ 417 (259)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (158,571) 417,292      
Issuance of common stock $ 1,283 5,883,078 5,884,361
Issuance of common stock (in Shares) 1,283,124      
Series A Convertible Preferred share issuance $ 10 99,990 100,000
Series A Convertible Preferred share issuance (in Shares) 10,000      
Conversion of notes payable - related party into Series A Convertible Preferred share issuance $ 190 1,899,810 1,900,000
Conversion of notes payable - related party into Series A Convertible Preferred share issuance (in Shares) 190,000      
Exercise of warrants $ 11 67,537 67,548
Exercise of warrants (in Shares) 11,075      
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee   $ 73 245,668   245,741
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee (in Shares)   73,156      
Settlement of disputed contractual claim $ 45 192,957 193,002
Settlement of disputed contractual claim (in Shares) 44,644      
Issuance of warrants in settlement of lease dispute 66,275 66,275
Shares issued in cashless exercise of warrants $ 4 (4)
Shares issued in cashless exercise of warrants (in Shares) 3,732      
Stock-based compensation related to founder’s transfers of common shares to contractors 5,322,930 5,322,930
Stock-based compensation related to employee and contractor equity awards $ 3 960,878 960,881
Stock-based compensation related to employee and contractor equity awards (in Shares) 3,290      
Stock and warrant dividend (1,705,722) (1,705,722)
Net Loss (8,851,310) (8,851,310)
Ending balance at Sep. 30, 2019 $ 661 $ 7,099 18,649,479 (10,333,283) 8,323,956
Ending balance (in Shares) at Sep. 30, 2019 660,567 7,099,471      
Balances at Jun. 30, 2019 $ 819 $ 6,584 17,895,657 (9,692,893) 8,210,167
Balances (in Shares) at Jun. 30, 2019 819,138 6,584,180      
Conversion of Series A Convertible Preferred Stock into common stock $ (158) $ 417 (259)    
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (158,571) 417,292      
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee   $ 73 245,668   245,741
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee (in Shares)   73,156      
Settlement of disputed contractual claim $ 25 74,975 75,000
Settlement of disputed contractual claim (in Shares) 24,843      
Stock based compensation 433,438 433,438
Net Loss (640,390) (640,390)
Ending balance at Sep. 30, 2019 $ 661 $ 7,099 18,649,479 (10,333,283) 8,323,956
Ending balance (in Shares) at Sep. 30, 2019 660,567 7,099,471      
Balances at Dec. 31, 2019 $ 579 $ 7,391 19,712,115 (12,794,473) 6,925,612
Balances (in Shares) at Dec. 31, 2019 578,567 7,390,261      
Conversion of Series A Convertible Preferred Stock into common stock $ (489) $ 1,286 (797)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (488,695) 1,286,042      
Settlement of Accounts Payable   $ 442 2,604,948 2,605,390
Settlement of Accounts Payable (in Shares)   441,567      
Shares issued in cashless exercise of warrants $ 416 (416)
Shares issued in cashless exercise of warrants (in Shares) 415,904      
Shares issued in cashless exercise of options $ 86 (86)
Shares issued in cashless exercise of options (in Shares) 86,424      
Warrants exercised for cash $ 7 38,563 38,570
Warrants exercised for cash (in Shares) 7,000      
Shares issued to current and former employees and directors $ 218 142,007 142,225
Shares issued to current and former employees and directors (in Shares) 218,402      
Stock based compensation     2,844,851   2,844,851
Net Loss (7,646,666) (7,646,666)
Ending balance at Sep. 30, 2020 $ 90 $ 9,846 25,341,185 (20,441,139) 4,909,982
Ending balance (in Shares) at Sep. 30, 2020 89,872 9,845,600      
Balances at Jun. 30, 2020 $ 95 $ 9,491 23,863,806 (17,693,926) 6,179,466
Balances (in Shares) at Jun. 30, 2020 94,872 9,490,582      
Conversion of Series A Convertible Preferred Stock into common stock $ (5) $ 13 (8)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (5,000) 13,158      
Settlement of Accounts Payable $ 157 847,043 847,200
Settlement of Accounts Payable (in Shares) 157,000      
Shares issued in cashless exercise of warrants $ 69 (69)
Shares issued in cashless exercise of warrants (in Shares) 68,715      
Shares issued in cashless exercise of options $ 29 (29)
Shares issued in cashless exercise of options (in Shares) 28,890      
Shares issued to current and former employees and directors $ 87 142,138 142,225
Shares issued to current and former employees and directors (in Shares) 87,255      
Stock based compensation     488,304   488,304
Net Loss (2,747,213) (2,747,213)
Ending balance at Sep. 30, 2020 $ 90 $ 9,846 $ 25,341,185 $ (20,441,139) $ 4,909,982
Ending balance (in Shares) at Sep. 30, 2020 89,872 9,845,600